
SpringWorks Therapeutics
Clinical-stage biopharmaceutical company that identifies and advances promising science and pioneers efficient pathways.
Market cap
$3.5b
Enterprise value
$3.3b
Share price
$46.99 SWTX
Authorizing premium user...
Clinical-stage biopharmaceutical company that identifies and advances promising science and pioneers efficient pathways.